Latest News
![Logo for Aracari](https://aracaribio.com/wp-content/uploads/2021/09/Aracari-Press-Logo-300x200.jpg)
Aracari Biosciences wins Startup World Cup Southern California 2022
IRVINE, CA, August 11th, 2022 – Aracari Biosciences, Inc. (“Aracari”) announced that it has won the Startup World Cup Southern California held on August 11th,
![Logo for Aracari](https://aracaribio.com/wp-content/uploads/2021/09/Aracari-Press-Logo-300x200.jpg)
Dr. Chris Hughes to speak at BioInsights’ Immuno-Oncology Insights
IRVINE, CA, June 1, 2022 – Aracari Biosciences, Inc. (“Aracari”) announced that Dr. Chris Hughes, Chief Scientific Officer, will be speaking at BioInsights’ Immuno-Oncology Insights
![Logo for Aracari](https://aracaribio.com/wp-content/uploads/2021/09/Aracari-Press-Logo-300x200.jpg)
Aracari Bioscience to present at first MPS World Summit
IRVINE, CA, May 31, 2022 – Aracari Biosciences, Inc. (“Aracari”) announced that it will present at the first MPS World Summit to be held in
![Logo for Aracari](https://aracaribio.com/wp-content/uploads/2021/09/Aracari-Press-Logo-300x200.jpg)
National Institute of Health (NIH) awards Aracari Biosciences to commercialize bone marrow platform that models in vivo drug responses
Aracari Biosciences, Inc. (“Aracari”) announced that it has received a grant from the National Institute of Health to further develop Aracari’s proprietary human bone marrow technology that models in vivo drug responses.
![Logo for Aracari](https://aracaribio.com/wp-content/uploads/2021/09/Aracari-Press-Logo-300x200.jpg)
National Science Foundation (NSF) awards Aracari Biosciences Phase II SBIR grant to commercialize the Vasoreactive Vascularized Micro-Organ (VMO-VA) platform
Aracari Biosciences, Inc. announces a Phase II Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) to commercialize its proprietary Vasoreactive Vascularized Micro-Organ (VMO-VA) platform.
![Logo for Aracari](https://aracaribio.com/wp-content/uploads/2021/09/Aracari-Press-Logo-300x200.jpg)
Aracari Biosciences wins Startup World Cup Southern California 2022
IRVINE, CA, August 11th, 2022 – Aracari Biosciences, Inc. (“Aracari”) announced that it has won the Startup World Cup Southern California held on August 11th,
![Logo for Aracari](https://aracaribio.com/wp-content/uploads/2021/09/Aracari-Press-Logo-300x200.jpg)
Dr. Chris Hughes to speak at BioInsights’ Immuno-Oncology Insights
IRVINE, CA, June 1, 2022 – Aracari Biosciences, Inc. (“Aracari”) announced that Dr. Chris Hughes, Chief Scientific Officer, will be speaking at BioInsights’ Immuno-Oncology Insights
![Logo for Aracari](https://aracaribio.com/wp-content/uploads/2021/09/Aracari-Press-Logo-300x200.jpg)
Aracari Bioscience to present at first MPS World Summit
IRVINE, CA, May 31, 2022 – Aracari Biosciences, Inc. (“Aracari”) announced that it will present at the first MPS World Summit to be held in
![Logo for Aracari](https://aracaribio.com/wp-content/uploads/2021/09/Aracari-Press-Logo-300x200.jpg)
National Institute of Health (NIH) awards Aracari Biosciences to commercialize bone marrow platform that models in vivo drug responses
Aracari Biosciences, Inc. (“Aracari”) announced that it has received a grant from the National Institute of Health to further develop Aracari’s proprietary human bone marrow technology that models in vivo drug responses.
![Logo for Aracari](https://aracaribio.com/wp-content/uploads/2021/09/Aracari-Press-Logo-300x200.jpg)
National Science Foundation (NSF) awards Aracari Biosciences Phase II SBIR grant to commercialize the Vasoreactive Vascularized Micro-Organ (VMO-VA) platform
Aracari Biosciences, Inc. announces a Phase II Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) to commercialize its proprietary Vasoreactive Vascularized Micro-Organ (VMO-VA) platform.